Meghna Sengupta on Muck Rack

Meghna Sengupta

Tamil Nādu
As seen in: Soccer Souls, Nature, Wiley Online Library, Bleacher Report, Mondaq, eplindex Liverpool FC, Bioprocess Online, Cell & Gene
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Meghna

Contact Meghna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reef island morphological change over the past two decades: Spermonde Archipelago, Indonesia

|
By Meghna Sengupta, Thomas Mann, Marleen Stuhr, Hildegard Westphal
| Wiley Online Library Verified
1 INTRODUCTION Across the tropical and sub-tropical oceans, reef islands occur as small, low-lying landforms, built predominantly from the deposition of biogenic carbonate sediments derived from coral reefs and related ecosystems, rarely reaching elevations > 2–3 m above mean sea-level (Stoddart & Steers, 1977; Woodroffe et al., 1999).
Open in Who Shared Issue with article?

Island change framework defines dominant modes of atoll island dynamics in response to environmental change - Communications Earth & Environment

|
By Paul Kench, Meghna Sengupta, Murray R. Ford
| Nature Verified
Abstract Climatic change threatens the persistence of atoll islands and the cultural and ecosystem services they support. However, adaptation and ecosystem management are constrained by lack of knowledge of island-specific transformations. We present an empirically-based island change framework that characterises the physical trajectory of islands, based on high-resolution shoreline analysis on 509 atoll islands in the central Pacific over the past half-century.
Open in Who Shared Issue with article?

12.11.23 -- Opportunities For AI To Assist Cell & Gene Therapy Companies

|
By Yoshio Hagiwara, Paolo Siciliano, Willem Van Asperen, Meghna Sengupta
| Bioprocess Online Verified
Accelerate Drug Development From Transfection To GMP Accelerating progress from cell line development to the production of GMP drug substance for Phase 1 and Phase 2 clinical trials is essential for success. At the same time, the need to align activities with funding milestones or adhere to a stepwise investment strategy imposes cost constraints. Our accelerated mAb development program shortens development timelines for IgG1 and IgG4 monoclonal antibodies to nine months. Learn more here.
Open in Who Shared Issue with article?
See all 15 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified